NCT00141661

Data

{
  "briefSummary": "A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.",
  "completionDate": "2006-06",
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": 67,
  "enrollmentType": "ACTUAL",
  "nctId": "NCT00141661",
  "phase": "PHASE2",
  "sponsorId": "pfizer",
  "startDate": "2005-10",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability of Two 10-Week Dose Regimens of Orally-Administered PF-04494700",
  "url": "https://clinicaltrials.gov/study/NCT00141661"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version